A detailed history of Assenagon Asset Management S.A. transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 1,204,994 shares of AMRX stock, worth $10.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,204,994
Previous 562,929 114.06%
Holding current value
$10.1 Million
Previous $3.57 Million 180.5%
% of portfolio
0.02%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$6.42 - $8.83 $4.12 Million - $5.67 Million
642,065 Added 114.06%
1,204,994 $10 Million
Q2 2024

Jul 18, 2024

BUY
$5.36 - $7.11 $87,861 - $116,547
16,392 Added 3.0%
562,929 $3.57 Million
Q1 2024

Apr 24, 2024

BUY
$5.24 - $6.34 $2.09 Million - $2.53 Million
399,492 Added 271.68%
546,537 $3.31 Million
Q4 2023

Jan 17, 2024

SELL
$3.36 - $6.21 $1.24 Million - $2.29 Million
-368,188 Reduced 71.46%
147,045 $892,000
Q3 2023

Nov 06, 2023

BUY
$2.76 - $4.59 $782,526 - $1.3 Million
283,524 Added 122.36%
515,233 $2.17 Million
Q2 2023

Jul 25, 2023

SELL
$1.33 - $3.1 $49,154 - $114,569
-36,958 Reduced 13.76%
231,709 $718,000
Q1 2023

Apr 18, 2023

BUY
$1.27 - $2.7 $249,033 - $529,440
196,089 Added 270.18%
268,667 $373,000
Q4 2022

Jan 12, 2023

BUY
$1.96 - $2.61 $142,252 - $189,428
72,578 New
72,578 $144,000
Q4 2021

Feb 01, 2022

SELL
$3.95 - $5.85 $116,592 - $172,674
-29,517 Closed
0 $0
Q2 2021

Jul 15, 2021

SELL
$5.12 - $6.82 $1.1 Million - $1.47 Million
-214,883 Reduced 87.92%
29,517 $151,000
Q1 2021

Apr 26, 2021

SELL
$4.74 - $7.38 $15,760 - $24,538
-3,325 Reduced 1.34%
244,400 $1.65 Million
Q4 2020

Feb 01, 2021

BUY
$3.95 - $5.42 $905,043 - $1.24 Million
229,125 Added 1231.85%
247,725 $1.13 Million
Q3 2020

Oct 07, 2020

SELL
$3.54 - $5.27 $2.22 Million - $3.3 Million
-626,720 Reduced 97.12%
18,600 $72,000
Q2 2020

Jul 21, 2020

BUY
$2.87 - $5.46 $1.85 Million - $3.52 Million
645,320 New
645,320 $3.07 Million
Q1 2020

Apr 17, 2020

SELL
$2.46 - $5.35 $83,797 - $182,242
-34,064 Closed
0 $0
Q4 2019

Jan 17, 2020

SELL
$2.65 - $5.56 $797,445 - $1.67 Million
-300,923 Reduced 89.83%
34,064 $164,000
Q3 2019

Oct 16, 2019

BUY
$2.29 - $7.1 $767,120 - $2.38 Million
334,987 New
334,987 $971,000

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.27B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.